Skip to main content
. 2014 Oct 31;4:278. doi: 10.3389/fonc.2014.00278

Figure 4.

Figure 4

Kaplan–Meier curves illustrate the survival of the patients who underwent whole pelvis radiotherapy with stereotactic body radiotherapy boost, including (A) overall survival; 4-year overall survival, 92.2% (B) biochemical recurrence-free survival; 4-year biochemical recurrence-free survival, 91.9%.